Industry Insights
-
Manufacturing Readiness: Why Compliance Is Won Or Lost On The Floor
8/6/2026
Achieve continuous regulatory readiness by embedding ALCOA++ compliance directly into manufacturing workflows to eliminate paper-based documentation risks.
-
What's Next For NAMs? Moving From Barriers To Breakthroughs
8/5/2026
The future of NAMs depends on robust biology, standardized practices, and submission-ready evidence that demonstrates value and strengthens regulatory trust.
-
Built To Move: Conformable Electronics And The Future Of Medical Wearables
8/5/2026
Advances in stretchable electronics and on-device intelligence are transforming wearable healthcare, enabling continuous monitoring, richer data, and real-time responses beyond clinics.
-
What 9 Years Of MDR Experience Is Changing About PMCF Planning
7/28/2026
Re-evaluate your compliance roadmap by exploring expert perspectives on navigating regulatory shifts, distinguishing core surveillance obligations, and building a defensible, value-driven clinical data strategy.
-
ICH E6(R3) Annex 2: Navigating GCP Requirements For Decentralized Trials
7/24/2026
Implementing decentralized components or real-world data requires proactive alignment with updated GCP standards for data access, remote consent, and multi-stream investigator oversight.
-
MHRA's 2026 Devices Reform: What Changes And When
7/22/2026
Great Britain’s draft medical device regulations realign requirements with EU MDR standards. Review transition timelines, technical document rules, and gap analysis strategies now.
-
Common Questions When Sourcing Tubing For Medical Devices
7/20/2026
Selecting medical tubing starts with the right questions. Explore materials, tolerances, customization options, and performance factors that support safe, reliable device designs.
-
Eliminate Fluidic Complexity: A Better Path For Instrument Performance Starts With A Reliable Supplier
7/20/2026
Simplify fluidic system design with leak-free fittings, high-purity tubing, and custom engineering that improve reliability, sensitivity, and scalability from prototype to production.
-
FDA's Risk-Based Inspection Shift: What It Actually Rewards
7/20/2026
FDA’s revised pre-approval inspection program prioritizes risk-based determinations over routine site visits. Review risk assessment factors and transition toward continuous audit readiness.
-
Selecting A Prefillable Syringe System With Confidence
7/17/2026
Prefilled syringe selection can stall drug development for months. This system integrates barrel, plunger, and needle shield from a single supplier, reducing complexity for emerging biotech.